SPSE:2928

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

JP¥132.4b

Last Updated

2021/06/11 08:56 UTC

Data Sources

Company Financials

Executive Summary

RIZAP GROUP, Inc. engages in beauty, health, and lifestyle related businesses in Japan. More Details


Snowflake Analysis

Adequate balance sheet and slightly overvalued.

Share Price & News

How has RIZAP GROUP's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2928 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 2928's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.


Market Performance


7 Day Return

12.8%

2928

1.8%

JP Personal Products

0.05%

JP Market


1 Year Return

42.5%

2928

1.2%

JP Personal Products

22.9%

JP Market

Return vs Industry: 2928 exceeded the JP Personal Products industry which returned 1.2% over the past year.

Return vs Market: 2928 exceeded the JP Market which returned 22.9% over the past year.


Shareholder returns

2928IndustryMarket
7 Day12.8%1.8%0.05%
30 Day15.0%5.2%3.8%
90 Day-2.1%-0.8%0.1%
1 Year42.5%42.5%2.4%1.2%25.6%22.9%
3 Year-70.4%-70.4%-17.8%-20.8%16.8%8.8%
5 Year8.1%6.0%87.1%74.9%72.8%53.8%

Long-Term Price Volatility Vs. Market

How volatile is RIZAP GROUP's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is RIZAP GROUP undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 2928 (¥238) is trading below our estimate of fair value (¥1652.51)

Significantly Below Fair Value: 2928 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 2928 is poor value based on its PE Ratio (116.7x) compared to the JP Personal Products industry average (36.2x).

PE vs Market: 2928 is poor value based on its PE Ratio (116.7x) compared to the JP market (16.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2928's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2928 is overvalued based on its PB Ratio (4.8x) compared to the JP Personal Products industry average (3x).


Future Growth

How is RIZAP GROUP forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.1%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RIZAP GROUP has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has RIZAP GROUP performed over the past 5 years?

-52.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2928 has high quality earnings.

Growing Profit Margin: 2928 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 2928's earnings have declined by 52.1% per year over the past 5 years.

Accelerating Growth: 2928 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2928 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (-17.7%).


Return on Equity

High ROE: 2928's Return on Equity (3.9%) is considered low.


Financial Health

How is RIZAP GROUP's financial position?


Financial Position Analysis

Short Term Liabilities: 2928's short term assets (¥85.5B) exceed its short term liabilities (¥71.1B).

Long Term Liabilities: 2928's short term assets (¥85.5B) exceed its long term liabilities (¥51.7B).


Debt to Equity History and Analysis

Debt Level: 2928's debt to equity ratio (83.4%) is considered high.

Reducing Debt: 2928's debt to equity ratio has reduced from 169.7% to 83.4% over the past 5 years.

Debt Coverage: 2928's debt is well covered by operating cash flow (76.1%).

Interest Coverage: 2928's interest payments on its debt are not well covered by EBIT (0.6x coverage).


Balance Sheet


Dividend

What is RIZAP GROUP current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 2928's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2928's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 2928's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2928's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 2928 is not paying a notable dividend for the JP market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 2928's dividend in 3 years as they are not forecast to pay a notable one for the JP market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average management tenure


CEO

Takeshi Seto (42 yo)

18.17yrs

Tenure

Mr. Takeshi Seto has been the President of RIZAP GROUP, Inc. since April 2003 which Mr. Seto established. Mr. Seto serves as President of Global Medical Research Institute Co., Ltd. He was President of Sys...


Leadership Team

Experienced Management: 2928's management team is considered experienced (2.4 years average tenure).


Board Members

Experienced Board: 2928's board of directors are not considered experienced ( 0.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

RIZAP GROUP, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: RIZAP GROUP, Inc.
  • Ticker: 2928
  • Exchange: SPSE
  • Founded: 2003
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: JP¥132.380b
  • Shares outstanding: 556.22m
  • Website: https://www.rizapgroup.com

Number of Employees


Location

  • RIZAP GROUP, Inc.
  • Shinjuku Front Tower
  • 31st Floor
  • Tokyo
  • 169-0074
  • Japan

Listings


Biography

RIZAP GROUP, Inc. engages in beauty, health, and lifestyle related businesses in Japan. It is also involved in the body makeup business; production, wholesale, and retail business of interior goods; sales ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/11 08:56
End of Day Share Price2021/06/10 00:00
Earnings2021/03/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.